Page last updated: 2024-12-06

1,1,2,3-tetrachloropropene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,1,2,3-tetrachloropropene: 1st & 5th sources for unspecified isomer; RN given refers to cpd with locants as specified; structure in third source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID25281
SCHEMBL ID151236
MeSH IDM0060915

Synonyms (24)

Synonym
tetrachloro-1-propene
1-propene, 1,1,2,3-tetrachloro-
1,1,2,3-tetrachloropropene
tetrachloropropene
1-propene, tetrachloro-
propene, 1,1,2,3-tetrachloro-
hsdb 6827
einecs 233-920-8
brn 1744014
1,1,2,3-tetrachloroprop-1-ene
AKOS006275023
413s8c56gb ,
10436-39-2
4-01-00-00751 (beilstein handbook reference)
unii-413s8c56gb
60320-18-5
SCHEMBL151236
1,1,2,3-tetrachloro-1-propene
1,1,2,3-tetrachloropropene [hsdb]
2,3,3-trichloroallyl chloride
DTXSID2051475
1,1,2,3-tetrachloro-1-propene #
AMY15516
Q27258384
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (62.50)18.7374
1990's3 (37.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.52 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (10.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]